Rare diseases
Investigational molecules
Locations
Back to Italy2 209 clinical trials in Rome, Italy across 15 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in ItalyStudi-Clinici.it(opens in a new tab)Study of long-term safety of octreotide subcutaneous depot (CAM2029) in patients with acromegaly
ItalyStudy on the Effectiveness and Safety of Finerenone for Adults with Non-Diabetic Chronic Kidney Disease
ItalyStudy on Afamelanotide and NB-UVB Light for Vitiligo Treatment in Patients with Vitiligo
ItalyStudy on Ribociclib, Topotecan, and Temozolomide for Children and Young Adults (12 months - 21 years) with Relapsed or Refractory Neuroblastoma and Solid Tumors
ItalyStudy of Durvalumab, Tremelimumab, and Lenvatinib with TACE for Patients with Liver Cancer (Hepatocellular Carcinoma)
ItalyLong-Term Study of BI 1015550 for Patients with Idiopathic Pulmonary Fibrosis and Progressive Pulmonary Fibrosis
ItalySafety and effectiveness study of DYNE-101 in patients with Myotonic Dystrophy Type 1 (DM1)
ItalyStudy on the Effects of AR1001 (Mirodenafil Dihydrochloride) for Patients with Early Alzheimer's Disease
ItalyItalyStudy on Advanced Liver Cancer: Evaluating Livmoniplimab and Budigalimab in Patients Without Prior Systemic Treatment
ItalyStudy of Nivolumab, Relatlimab and Bevacizumab combination for patients with untreated advanced or metastatic liver cancer (hepatocellular carcinoma)
ItalyStudy of intravenous zanamivir safety and effectiveness in infants under 6 months of age with complicated influenza infection
ItalyThe busiest research cities in the country
What the registry says about research in the country
Clinical studies focusing on Idiopathic Pulmonary Fibrosis and COPD, evaluating new therapeutic approaches for improving lung function and reducing disease progression.
Advanced research includes novel antibody treatments and preventive measures for respiratory infections.
Innovative trials targeting metastatic colorectal cancer, gastric cancer, and acute myeloid leukemia, exploring new treatment combinations and targeted therapies.
Studies focus on improving response rates and survival outcomes in various cancer types.
Research into Parkinson's disease and acute ischemic stroke, investigating novel therapeutic approaches and neuroprotective strategies.
Studies aim to improve neurological outcomes and patient quality of life.
Clinical trials examining Immune Thrombocytopenia and Hidradenitis Suppurativa, testing new therapeutic agents for immune-mediated conditions.
Research focuses on improving treatment outcomes in challenging immune disorders.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
